Acacia Pharma

Acacia Pharma Ltd. discovers and develops supportive care drugs. The company focuses on cancer supportive treatment. Its products include APD405, an injectable formulation of an oral drug for nausea and vomiting; APD209, for cancer cachexia; and APD421, an intravenous formulation for the prevention and treatment of nausea and vomiting.